Lv1
26 积分 2024-07-09 加入
GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy
4小时前
已完结
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
3个月前
已完结
Fibrous polyisocyanide hydrogels for 3D cell culture applications
3个月前
已完结
Hydrogels for 3D Cell Culture
3个月前
已完结
Design, Structure Optimization, and Preclinical Characterization of JAB-21822, a Covalent Inhibitor of KRASG12C
4个月前
已完结
Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical model
5个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
Competitive SPR chaser assay to study biomolecular interactions with very slow binding dissociation rate constant
7个月前
已完结
The emergence of pan-KRAS drugs
7个月前
已完结
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display
9个月前
已完结
皖公网安备34019202002308
